tiprankstipranks
Trending News
More News >
iTeos Therapeutics (ITOS)
NASDAQ:ITOS
US Market

iTeos Therapeutics (ITOS) Technical Analysis

Compare
192 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
iTeos Therapeutics’s (ITOS) Moving Averages Convergence Divergence (MACD) indicator is 0.39, suggesting iTeos Therapeutics is a Buy.
iTeos Therapeutics’s (ITOS) 20-Day exponential moving average is 9.79, while iTeos Therapeutics’s (ITOS) share price is $10.02, making it a Buy.
iTeos Therapeutics’s (ITOS) 50-Day exponential moving average is 8.90, while iTeos Therapeutics’s (ITOS) share price is $10.02, making it a Buy.

iTeos Therapeutics (ITOS) Pivot Points

Jun 28, 2025, 06:58 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.81
9.88
9.95
10.03
10.10
10.17
10.24
Fibonacci
9.88
9.94
9.97
10.03
10.08
10.11
10.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

iTeos Therapeutics (ITOS) Moving Averages

Jun 28, 2025, 06:58 PM
Period
Simple
Exponential
MA5
10.04Sell
10.01Sell
MA10
10.05Sell
10.01Sell
MA20
10.06Sell
9.79Buy
MA50
8.58Buy
8.90Buy
MA100
7.67Buy
8.50Buy
MA200
8.33Buy
9.64Buy
iTeos Therapeutics’s (ITOS) 10-Day exponential moving average is 10.01, while iTeos Therapeutics’s (ITOS) share price is $10.02, making it a Sell.
iTeos Therapeutics’s (ITOS) 100-Day exponential moving average is 8.50, while iTeos Therapeutics’s (ITOS) share price is $10.02, making it a Buy.
iTeos Therapeutics’s (ITOS) stock price is $10.02 and iTeos Therapeutics’s (ITOS) 50-day simple moving average is 8.58, creating a Buy signal.
iTeos Therapeutics’s (ITOS) stock price is $10.02 and iTeos Therapeutics’s (ITOS) 100-day simple moving average is 7.67, creating a Buy signal.
iTeos Therapeutics’s (ITOS) stock price is $10.02 and iTeos Therapeutics’s (ITOS) 200-day simple moving average is 8.33, creating a Buy signal.

iTeos Therapeutics (ITOS) Technical Indicators

Jun 28, 2025, 06:58 PM
Name
Value
Implied Action
RSI (14)
62.25
Neutral
STOCH (9,6)
31.64
Neutral
STOCHRSI (14)
24.52
Neutral
MACD (12,26)
0.39
Buy
ADX (14)
45.97
Neutral
Williams %R
-86.44
Buy
CCI (14)
-116.98
Buy
ATR (14)
0.28
-
Ultimate Oscillator
39.04
Neutral
ROC
-2.16
Sell
iTeos Therapeutics’s (ITOS) Relative Strength Index (RSI) is 62.25, creating a Neutral signal.
iTeos Therapeutics’s (ITOS) Trend Strength Indicator (ADX) is 45.97, creating a Neutral signal.
iTeos Therapeutics’s (ITOS) Commodity Channel Index (CCI) is -116.98, creating a Buy signal.
iTeos Therapeutics’s (ITOS) Price Rate of Change (ROC) is -2.16, creating a Sell signal.

FAQ

Is ITOS a Buy, Hold, or Sell?
Based on ITOS’s technical indicators, ITOS is a Buy.
    What is ITOS’s RSI (14)?
    ITOS’s RSI (14) is 62.25, which suggests ITOS is a Neutral.
      What is ITOS’s MACD?
      ITOS’s MACD is 0.39, which suggests ITOS is a Buy.
        What is ITOS’s 5-day moving average?
        ITOS’s 5-day moving average is 10.04, which suggests ITOS is a Sell.
          What is ITOS’s 20-day moving average?
          ITOS 20-day moving average is 10.06, which suggests ITOS is a Sell.
            What is ITOS’s 50-day moving average?
            ITOS’s 50-day moving average is 8.58, which suggests ITOS is a Buy.
              What is ITOS’s 200-day moving average?
              ITOS’s 200-day moving average is 8.33, which suggests ITOS is a Buy.
                What is ITOS’s Williams % R (14)?
                ITOS’s Williams % R (14) is -86.44, which suggests ITOS is a Buy.
                  What is ITOS’s CCI (14)?
                  ITOS’s CCI (14) is -116.98, which suggests ITOS is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis